Most Read Articles
Tristan Manalac, 22 Mar 2018
The prevalence rates of diabetes mellitus (DM) and dyslipidaemia are higher in long-stay inpatients with schizophrenia than in the general population, a recent Singapore study has shown. Despite this, the two conditions appear to be well-controlled, possibly because of the supervised diets and regular physical activities that inpatients receive.

Management of dementia beyond cognition – a deeper look into BPSD and CVD

13 Dec 2017
Brain tricks: The fact that déjà vu occurs so randomly and rapidly—and in individuals without a medical condition—makes it difficult to study, and why and how the phenomenon occurs is up to much speculation.
At the Schwabe-Menarini lunch symposium of the 11th International Congress of the Asian Society Against Dementia (ASAD) 2017 held in Bangkok, Thailand, Professor Ralf Ihl highlighted the role of standardized Gingko biloba extract EGb 761® for the treatment of patients with behavioural and psychological symptoms of dementia (BPSD). Meanwhile, Associate Professor Nagaendran Kandiah presented clinical findings on the association between cerebrovascular disease (CVD) and dementia, and emphasized the role of EGb 761® in the management of dementia with CVD.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Tristan Manalac, 22 Mar 2018
The prevalence rates of diabetes mellitus (DM) and dyslipidaemia are higher in long-stay inpatients with schizophrenia than in the general population, a recent Singapore study has shown. Despite this, the two conditions appear to be well-controlled, possibly because of the supervised diets and regular physical activities that inpatients receive.